AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionHarfst & Associates, Inc.
Latest Disclosed Ownership2,621 shares
Latest Disclosed Value $ 570,042
Harfst & Associates, Inc. ownership in ABBV / AbbVie Inc.

On May 12, 2026 - Harfst & Associates, Inc. filed a 13F-HR form disclosing ownership of 2,621 shares of AbbVie Inc. (US:ABBV) valued at $570,041 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 2,621 shares of AbbVie Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $589,568 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBVIE COM 00287Y109 2,621 0 0.00 570 -4.68 0.1018
2026-02-10 2025-12-31 13F ABBVIE COM 00287Y109 2,621 0 0.00 599 -1.32 0.1080
2025-10-23 2025-09-30 13F ABBVIE COM 00287Y109 2,621 -10 -0.38 607 24.18 0.1119
2025-08-13 2025-06-30 13F ABBVIE COM 00287Y109 2,631 -10 -0.38 488 -11.75 0.1007
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 2,641 0 0.00 553 17.91 0.1279
2025-02-05 2024-12-31 13F ABBVIE COM 00287Y109 2,641 0 0.00 469 -9.98 0.0978
2024-10-18 2024-09-30 13F ABBVIE COM 00287Y109 2,641 -40 -1.49 522 13.51 0.1171
2024-08-01 2024-06-30 13F ABBVIE COM 00287Y109 2,681 0 0.00 460 -5.94 0.1072
2024-08-01 2024-03-31 13F/A-1 ABBVIE COM 00287Y109 2,681 0 0.00 488 17.59 0.1159
2024-02-07 2023-12-31 13F ABBVIE COM 00287Y109 2,681 0 0.00 415 4.01 0.1097
2023-11-07 2023-09-30 13F ABBVIE COM 00287Y109 2,681 -235 -8.06 400 1.79 0.1122
2023-08-07 2023-06-30 13F ABBVIE COM 00287Y109 2,916 235 8.77 393 -8.20 0.1046
2023-05-10 2023-03-31 13F ABBVIE COM 00287Y109 2,681 0 0.00 427 -1.39 0.1225
2023-02-13 2022-12-31 13F ABBVIE COM 00287Y109 2,681 0 0.00 433 20.28 0.1250
2022-10-28 2022-09-30 13F ABBVIE COM 00287Y109 2,681 0 0.00 360 -12.20 0.1083
2022-07-28 2022-06-30 13F ABBVIE COM 00287Y109 2,681 0 0.00 410 -5.53 0.1164
2022-04-28 2022-03-31 13F ABBVIE COM 00287Y109 2,681 -55 -2.01 434 17.30 0.1008
2022-02-07 2021-12-31 13F ABBVIE COM 00287Y109 2,736 55 2.05 370 28.03 0.0942
2021-10-28 2021-09-30 13F ABBVIE COM 00287Y109 2,681 0 0.00 289 -3.99 0.0799
2021-08-11 2021-06-30 13F ABBVIE COM 00287Y109 2,681 0 0.00 301 3.79 0.0872
2021-05-10 2021-03-31 13F ABBVIE COM 00287Y109 2,681 0 0.00 290 1.05 0.0874
2021-01-25 2020-12-31 13F ABBVIE COM 00287Y109 2,681 0 0.00 287 22.65 0.1055
2020-11-04 2020-09-30 13F ABBVIE COM 00287Y109 2,681 16 0.60 234 -10.34 0.0990
2020-08-07 2020-06-30 13F ABBVIE COM 00287Y109 2,665 0 0.00 261 28.57 0.1122
2020-05-05 2020-03-31 13F ABBVIE COM 00287Y109 2,665 0 0.00 203 -13.62 0.1032
2020-02-14 2019-12-31 13F ABBVIE COM 00287Y109 2,665 0 0.00 235 16.92 0.0905
2019-11-14 2019-09-30 13F ABBVIE COM 00287Y109 2,665 2,665 201 0.0827
2019-08-14 2019-06-30 13F ABBVIE COM 00287Y109 0 -2,695 -100.00 0 -100.00
2019-05-01 2019-03-31 13F ABBVIE COM 00287Y109 2,695 0 0.00 217 -12.50 0.0928
2019-02-06 2018-12-31 13F ABBVIE COM 00287Y109 2,695 0 0.00 248 -2.36 0.1186
2018-10-31 2018-09-30 13F ABBVIE COM 00287Y109 2,695 0 0.00 254 2.01 0.1085
2018-08-10 2018-06-30 13F ABBVIE COM 00287Y109 2,695 0 0.00 249 -2.35 0.1052
2018-05-04 2018-03-31 13F ABBVIE COM 00287Y109 2,695 475 21.40 255 19.16 0.1040
2018-02-09 2017-12-31 13F ABBVIE COM 00287Y109 2,220 2,220 214 0.0866
2017-11-07 2017-09-30 13F ABBVIE COM 00287Y109 0 -2,220 -100.00 0 -100.00
2017-08-11 2017-06-30 13F ABBVIE COM 00287Y109 2,220 -592 -21.05 160 -12.57 0.0646
2017-05-12 2017-03-31 13F ABBVIE COM 00287Y109 2,812 -1,334 -32.18 183 -29.34 0.0791
2017-02-02 2016-12-31 13F ABBVIE COM 00287Y109 4,146 -145 -3.38 259 -4.07 0.1294
2016-11-14 2016-09-30 13F ABBVIE COM 00287Y109 4,291 387 9.91 270 12.03 0.1423
2016-08-05 2016-06-30 13F ABBVIE COM 00287Y109 3,904 -1,872 -32.41 241 -26.75 0.0972
2016-05-03 2016-03-31 13F ABBVIE COM 00287Y109 5,776 -104 -1.77 329 -5.46 0.2137
2016-02-05 2015-12-31 13F ABBVIE COM 00287Y109 5,880 300 5.38 348 14.47 0.1417
2015-11-09 2015-09-30 13F ABBVIE COM 00287Y109 5,580 726 14.96 304 -6.75 0.1333
2015-08-06 2015-06-30 13F ABBVIE COM 00287Y109 4,854 4,854 326 0.1830
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.